Sonic Incytes Medical Corp.

Sonic Incytes is redefining the standard of care in quantifying liver stiffness and attenuation. Recognizing the rise of fatty liver disease, we’ve made it our mission to make liver health a new vital sign. Our novel, portable, handheld solution assesses liver attenuation with ultrasound, and liver stiffness with technology similar to that of MRI elastography, the current non-invasive gold standard. Velacur aids in the clinical management of patients with liver disease, with measurements you can count on. Founded in 2017, Sonic Incytes Medical Corp. is a medical device company headquartered in Vancouver, Canada. We’ve cultivated strong partnerships for the benefit of patients worldwide.